Fierce Biotech

Shionogi pays Apnimed $100M for joint venture to awaken sleep disorder dream

Published

2 weeks ago

on

Shionogi has struck a deal to take full control of its sleep disorder joint venture, agreeing to pay Apnimed $100 million upfront for its partner’s half of the business.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version